Immunohistochemistry was performed in brain regions containing abundant tau pathology in each disease; hippocampus for AD, MCI, and PiD and frontal cortex for CBD, PSP, and PiD. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.